Insulin glargine and lixisenatide Subcutaneous and Methyldopa Oral, Intravenous
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Methyldopa Oral, Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: methyldopa
Brand name: Aldomet
Synonyms: Methyldopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Methyldopa Tablets
- Insulin glargine and lixisenatide Subcutaneous-Methyldopate
- Insulin glargine and lixisenatide Subcutaneous-Methyldopate hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Methylene Blue
- Insulin glargine and lixisenatide Subcutaneous-Methylene blue injection
- Insulin glargine and lixisenatide Subcutaneous-Methylene blue Oral, Intravenous
- Methyldopa Oral, Intravenous-Insulin glargine, recombinant Subcutaneous
- Methyldopa Oral, Intravenous-Insulin glulisine
- Methyldopa Oral, Intravenous-Insulin Glulisine (Cartridges and Pens)
- Methyldopa Oral, Intravenous-Insulin Glulisine (Vials)
- Methyldopa Oral, Intravenous-Insulin glulisine Subcutaneous
- Methyldopa Oral, Intravenous-Insulin human inhaled Inhalation